Microwave Ablation Combined with Stereotactic Radiotherapy for Primary and Recurrent Hepatocellular Carcinoma after Interventional Treatment

ZHANG Jiangzhou; LONG Zhixiong

doi:10.3971/j.issn.1000-8578.2014.06.031

Cancer Research on Prevention and Treatment > 2014 > 41(06): 649-652. > DOI: 10.3971/j.issn.1000-8578.2014.06.031

ZHANG Jiangzhou, LONG Zhixiong. Microwave Ablation Combined with Stereotactic Radiotherapy for Primary and Recurrent Hepatocellular Carcinoma after Interventional Treatment[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 649-652. DOI: 10.3971/j.issn.1000-8578.2014.06.031

Citation:

PDF (1123 KB)

Microwave Ablation Combined with Stereotactic Radiotherapy for Primary and Recurrent Hepatocellular Carcinoma after Interventional Treatment

ZHANG Jiangzhou,
LONG Zhixiong^,

Second Department of Oncology, 5th Hospital of Wuhan City, Wuhan 430050,China

More Information

Received Date: May 21, 2013
Revised Date: December 01, 2013

Graphical Abstract

Abstract

Abstract

Abstract：Objective To assess microwave ablation combined with stereotactic radiotherapy for primary and recurrent hepatocellular carcinoma after interventional treatment. Methods The clinical data of 106 primary and recurrent liver cancer patients in the fifth Hospital of Wuhan City in recent years were retrospectively analyzed．All patients were equally divided into control group (CG) and observation group(OG). OG group received stereotactic radiotherapy which was conformal intensity modulated radiotherapy, and then microwave ablation. CG group only received stereotactic radiotherapy. Short-term effects,survival rates and clinical features were compared between two groups. Results Total response rates of CG and OG were 62.26% and 79.25%(P <0.05)．1-year survival rate of OG group was higher than that in CG group(P <0.05).Quality of life in two groups before and after treatment and serum AFP had no statistical significance(P>0.05). Incidences of nausea,vomiting, fever,leucocyte decline,radioactive hepatitis and peptic ulcer in two groups during and after treatment had no statistical signifi cance(P >0.05). Conclusion Curative effect of microwave ablation combined with stereotactic radiotherapy regimen for primary and recurrent hepatocellular carcinoma is reliable，with mild adverse reactions, and worthy of further clinical research．
- Radiotherapy,
- Primary hepatic carcinoma,
- Microwave ablation,
- Clinical effi cacy

FullText(HTML)

References (11)

References

[1]	Yu ZH. Primary liver cancer[M]//Ying WB, Yu ZH,Xu GZ,et al.Radiation oncology.Beijing:China Union Medical University Press,2008:829-35. [余子豪.原发性肝癌[M]//殷蔚伯,余子豪, 徐国镇,等.肿瘤放射治疗学.北京:中国协和医科大学出版社,2008:829-35.]
[2]	Livraghi T,Mäkisalo H,Line PD. Treatment options in hepatocellular carcinoma today[J].Scand J Surg,2011,100(1): 22-9.
[3]	Leneioni R,Chen XP,Dagher L,et al.Treatment of intermediate/ advanced hepatocellular carcinoma in the clinic:how can outcomes be improved? [J].Oncologist,2010,15 Suppl 4:42-52.
[4]	Chinese Society of Liver Cancer, Chinese Society of Clinical Oncology,Chinese Society of Hepatology Liver Cancer Group. Expert consensus on standardization of the management of primary liver cancer[J].Zhong Liu,2009,29(4):295-304.[中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].肿瘤,2009,29(4):295-304.]
[5]	Gao F,Gu YK,Fan WJ,et al.Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma[J].World J Gastroenterol.2011,17 (26):3145-50.
[6]	Feng M,Ben-Josef E.Radiation therapy for hepatocellular carcinoma [J].Semin Radiat Oncol,2011,21(4):271-7.
[7]	Hoffe SE,Finkelstein SE,Russell MS,et al.Nonsurgical options for hepatocellular carcinoma:evolving role of external beam radiotherapy [J].Cancer Control,2010,17(2):100-10.
[8]	Zhang YW, Zhang Y,Ling ZH,et al. Meta analysis of curative effect of liver cancer with three dimensional conformal radiotherapy combined with TACE and TACE Alone[J]. Nan Fang Yi Ke Da Xue Xue Bao,2009,29(12):2514-6．[张耀伟,张勇,凌志海,等.三维适形放疗联合TACE与单纯TACE治疗肝癌疗效的 meta分析[J]. 南方医科大学学报, 2009,29 (12):2514-6.]
[9]	Liang SX, Jiang GL, Zhu XD, et al. Radiation-induced liver disease: risk factors and liver irradiation tolerance[J].Ai Zheng Jin Zhan,2006,4(4):308-13.[ 梁世雄,蒋国梁,朱小东,等.放射性肝病影响因素及肝脏放射耐受剂量的研究[J].癌症进展,2006,4(4):308-13.]
[10]	Webb H,Lubner MG,Hinshaw JL.Thermal ablation[J].Semin Roentgenol,2011,46(2):133-41.
[11]	Bhardwaj N,Dormer J,Ahmad F,et al.Microwave ablation of the liver: a description of lesion evolution over time and an investigation of the heat sink effect[J].Pathology,2011,43(7):725-31.

[1]	ZHOU Yan, DING Jianmin, WANG Yandong, JING Xiang. Current Status and Challenges of Ultrasound-Guided Ablation Therapy for Liver Cancer[J]. Cancer Research on Prevention and Treatment, 2025, 52(4): 274-280. DOI: 10.3971/j.issn.1000-8578.2025.24.1070
[2]	YU Chen, WANG Wei, FU Guang, ZHAO Duanyi, GONG Jianping. Clinical Efficacy of Concept of Membrane Anatomy with Complete Mesangectomy in Radical Resection of Rectal Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(8): 777-781. DOI: 10.3971/j.issn.1000-8578.2023.23.0122
[3]	HE Yisheng, BAO Liangliang, YU Jiawen, Lyu Yang. Clinical Efficiency and Safety of Hypofractionated Thoracic Radiotherapy Combined with EP Chemotherapy on Patients with Limited-stage Small-cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(2): 170-174. DOI: 10.3971/j.issn.1000-8578.2023.22.0848
[4]	REN Jianwei, ZHOU Zubang, MA Wenjuan, YANG Daxiong, REN Yiqun, ZHANG Zhi, NIU Yanqiang, CAO Lei. Expression of PD-L1 in Primary Colorectal Cancer and Its Predictive Value for Recurrence After Microwave Ablation of Liver Metastases[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 38-42. DOI: 10.3971/j.issn.1000-8578.2023.22.0538
[5]	YANG Zhizheng, XIAO shuchao, LI Jing. Clinical Effects of Huangqi Guizhi Wuwu Decoction and Neixiao Pill Cutting Assisted with External Treatment of Traditional Chinese Medicine on Breast Cancer Patients with Postoperative Upper Limb Lymphedema[J]. Cancer Research on Prevention and Treatment, 2020, 47(12): 958-962. DOI: 10.3971/j.issn.1000-8578.2020.19.1323
[6]	WANG Jing, JIA Jinghao, LIU Jingjing, CUI Zhichao, XIONG Wei, WANG Xiaohong. Clinical Observation of Apatinib in Treatment of Refractory Advanced Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2020, 47(11): 861-865. DOI: 10.3971/j.issn.1000-8578.2020.19.1305
[7]	XIAO Jincheng, GUO Leiming, KANG Xinxin, BAI Qiwen, ZHANG Junling, LI Jing. Comparison of Efficiency and Safety Between Radiofrequency Ablation and Stereotactic Body Radiotherapy on Primary Small Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 831-835. DOI: 10.3971/j.issn.1000-8578.2017.17.0613
[8]	SUN Zhen, YANG Xiaojun, CHENG Fulin, YANG Guoliang, XIONG Bin, LI Yan. Clinical Efficacy of Neoadjuvant Chemotherapy with FOLFOX4 Regimen in Advanced Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(07): 803-807. DOI: 10.3971/j.issn.1000-8578.2014.07.025
[9]	CHANG Lin, ZONG Hong, WANG Liuxing, FAN Qingxia, WANG Ruilin. Clinical Study of Bevacizumab Combined with FOLFIRI Regimen in Treatment of Advanced Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(05): 485-488. DOI: 10.3971/j.issn.1000-8578.2013.05.018
[10]	JIANG Lin, KONG Qing-zhi, HU Xian-zhu. Clinical Analysis of Whole Body Gamma Knife Combined with DP Regimen for Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(12): 1431-1433. DOI: 10.3971/j.issn.1000-8578.2011.12.024

Cited By

Get Citation

PDF

XML

Article views (1665) PDF downloads (618)

Turn off MathJax

Article Contents

Abstract

References

Microwave Ablation Combined with Stereotactic Radiotherapy for Primary and Recurrent Hepatocellular Carcinoma after Interventional Treatment

Abstract

References

Related Articles

Catalog

Contact Us

Microwave Ablation Combined with Stereotactic Radiotherapy for Primary and Recurrent Hepatocellular Carcinoma after Interventional Treatment

Abstract

References

Related Articles

Catalog

Contact Us

Export File

Citation

Format

Content